Free Trial

Shuttle Pharmaceuticals (SHPH) Competitors

Shuttle Pharmaceuticals logo
$0.62 +0.02 (+3.70%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.61 -0.01 (-1.13%)
As of 02/21/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SHPH vs. PMCB, CHRO, TLPH, KPRX, KLTO, JAGX, BCLI, PHXM, CSCI, and AIMD

Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include PharmaCyte Biotech (PMCB), Chromocell Therapeutics (CHRO), Talphera (TLPH), Kiora Pharmaceuticals (KPRX), Klotho Neurosciences (KLTO), Jaguar Health (JAGX), Brainstorm Cell Therapeutics (BCLI), PHAXIAM Therapeutics (PHXM), COSCIENS Biopharma (CSCI), and Ainos (AIMD). These companies are all part of the "pharmaceutical products" industry.

Shuttle Pharmaceuticals vs.

Shuttle Pharmaceuticals (NASDAQ:SHPH) and PharmaCyte Biotech (NASDAQ:PMCB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Shuttle Pharmaceuticals and PharmaCyte Biotech both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Shuttle PharmaceuticalsN/AN/A
PharmaCyte BiotechN/AN/A

4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 34.2% of PharmaCyte Biotech shares are owned by institutional investors. 39.6% of Shuttle Pharmaceuticals shares are owned by company insiders. Comparatively, 1.0% of PharmaCyte Biotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

PharmaCyte Biotech's return on equity of 0.76% beat Shuttle Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Shuttle PharmaceuticalsN/A -583.02% -258.92%
PharmaCyte Biotech N/A 0.76%0.45%

Shuttle Pharmaceuticals has a beta of -1.75, indicating that its stock price is 275% less volatile than the S&P 500. Comparatively, PharmaCyte Biotech has a beta of -0.18, indicating that its stock price is 118% less volatile than the S&P 500.

In the previous week, Shuttle Pharmaceuticals' average media sentiment score of 0.00 equaled PharmaCyte Biotech'saverage media sentiment score.

Company Overall Sentiment
Shuttle Pharmaceuticals Neutral
PharmaCyte Biotech Neutral

Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than PharmaCyte Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.15
PharmaCyte BiotechN/AN/A$330K$0.533.32

Summary

PharmaCyte Biotech beats Shuttle Pharmaceuticals on 7 of the 8 factors compared between the two stocks.

Get Shuttle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHPH vs. The Competition

MetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.43M$7.07B$5.84B$9.15B
Dividend YieldN/A2.75%4.75%3.85%
P/E Ratio-0.155.4725.4719.00
Price / SalesN/A306.08447.5876.30
Price / CashN/A65.6738.0134.83
Price / Book0.306.717.644.62
Net Income-$6.59M$138.33M$3.18B$245.85M
7 Day Performance-11.82%-2.61%-1.99%-2.68%
1 Month Performance-37.10%-2.32%-0.42%-2.19%
1 Year PerformanceN/A-5.31%16.51%12.84%

Shuttle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHPH
Shuttle Pharmaceuticals
N/A$0.62
+3.7%
N/AN/A$2.43MN/A-0.155Gap Up
High Trading Volume
PMCB
PharmaCyte Biotech
N/A$1.63
-0.6%
N/A-14.6%$11.36MN/A3.084High Trading Volume
CHRO
Chromocell Therapeutics
N/A$1.88
+8.7%
N/A-64.9%$11.33MN/A0.004
TLPH
Talphera
2.5541 of 5 stars
$0.65
+2.7%
$4.33
+568.7%
-50.8%$11.04M$650,000.00-0.9419
KPRX
Kiora Pharmaceuticals
2.2185 of 5 stars
$3.62
+0.6%
$10.00
+176.2%
-35.3%$10.86M$16M0.0010News Coverage
KLTO
Klotho Neurosciences
N/A$0.40
+8.4%
N/AN/A$10.83MN/A0.00N/AGap Up
High Trading Volume
JAGX
Jaguar Health
0.3116 of 5 stars
$0.90
+5.3%
N/A-78.8%$10.62M$9.76M0.0050Gap Up
BCLI
Brainstorm Cell Therapeutics
4.0752 of 5 stars
$1.86
+3.3%
$30.00
+1,512.9%
-62.9%$10.60MN/A-0.3940Analyst Forecast
News Coverage
PHXM
PHAXIAM Therapeutics
N/A$3.10
flat
N/AN/A$10.58M$32.66M0.0049
CSCI
COSCIENS Biopharma
N/A$2.76
-2.5%
N/AN/A$10.43M$4.50M-0.2320
AIMD
Ainos
0.4076 of 5 stars
$0.74
+1.2%
N/A-23.5%$10.41M$120,000.000.0040Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners